Drug
Voriconazole clinical trials
Also written Vfend.
- studies test it
- 81
- open now
- 2
- in phase 3
- 22
- first study started
- 1997
Keep track of what changes. Save the Voriconazole studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
- Vfend
- 20
Studies by the year they started
81 studies that test it; most in 2008 (11)
| Year | Studies |
|---|---|
| 1997 | 3 |
| 1999 | 2 |
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 7 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 11 |
| 2009 | 7 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 2 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 24
- Phase 2
- 16
- Phase 3
- 22
- Phase 4
- 17
- No phase
- 6
What it is tested for
Each study’s main condition, where its own words name it.
- Mycoses
- 17
Who runs them
Industry 32 · Other 49
Pfizer (20) · Seoul National University Hospital (5) · National Cancer Institute (NCI) (5) · University of California, San Francisco (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Bristol-Myers Squibb (2) · Post Graduate Institute of Medical Education and Research, Chandigarh (2) · Yung Shin Pharm. Ind. Co., Ltd. (2)
Often tested with
Tested in the same studies.
Amphotericin B (5) · Anidulafungin (4) · Itraconazole (3) · Fluconazole (2) · Micafungin (2) · Repotrectinib (1) · Quinidine (1) · Ciprofol (1)
Studies
Open first, then newest update. How each study uses Voriconazole is read from its arms, and is right about nine times in ten.
Testing it · 81
- Study on the Drug Interaction Between Buagafuran and VoriconazoleNot yet recruitingPhase 1Beijing Union Pharmaceutical Factory LtdNCT07457203Written as Voriconazole
- Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous LeishmaniasisRecruitingPhase 3Zagazig UniversityNCT05708625Written as Intralesional Voriconazole
- A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT06493409Written as Voriconazole
- Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune SystemsTerminatedPhase 2OHSU Knight Cancer InstituteNCT00238355Written as voriconazole
- A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary AspergillosisCompletedPhase 3Post Graduate Institute of Medical Education and Research, ChandigarhNCT04824417Written as Voriconazole 200mg
- ATCF (Azole Therapy in Cystic Fibrosis)CompletedPhase 2Rennes University HospitalNCT01576315Written as Itraconazole/voriconazole
- Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)CompletedPhase 3Medical College of WisconsinNCT00075803Written as Voriconazole
- Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic SubjectsCompletedPhase 1Zambon SpANCT04229303Written as oral voriconazole
- Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host DiseaseTerminatedPhase 1National Institutes of Health Clinical Center (CC)NCT01950507Written as Voriconazole
- Three Induction Treatments on Cryptococcal MeningitisStatus unknownEarly Phase 1First Affiliated Hospital of Zhejiang UniversityNCT04072640Written as Voriconazole 200mg
- A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Voriconazole TabletsCompletedPhase 1Sichuan Haisco Pharmaceutical Group Co., LtdNCT04145583Written as voriconazole +HSK3486
- Amphotericin-B and Voriconazole for Pulmonary BlastomycosisTerminatedPhase 4University of ManitobaNCT02283905Written as voriconazole
- Evaluate Bioequivalence of Voriconazole(200mg/Vial) .CompletedPhase 4Yung Shin Pharm. Ind. Co., Ltd.NCT04552353Written as Vaway
- Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationCompletedNot applicableJonsson Comprehensive Cancer CenterNCT00079222Written as voriconazole
- Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy VolunteersCompletedPhase 1Chong Kun Dang PharmaceuticalNCT02631954Written as Vorico Injection 200mg(Voriconazole)
- MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant PatientsCompletedPhase 1Masonic Cancer Center, University of MinnesotaNCT02227797Written as Voriconazole
- The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs PlaceboCompletedPhase 3University of California, San FranciscoNCT00997035Written as Voriconazole
- Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole TherapyStatus unknownNot applicableGuangxi Medical UniversityNCT03827278Written as Voriconazole
- Pilot Study to Compare Topical Voriconazole to Placebo as a Pain Reducing AgentWithdrawnPhase 2Kenneth HargreavesNCT02689713Written as Voriconazole (topical)
- A Study to Evaluate the Appropriateness of the Voriconazole Dosing RegimenCompletedPhase 1Seoul National University HospitalNCT03760276Written as Voriconazole Oral Product (Vfend®)
See all 81 studies that test Voriconazole →
Given in every arm · 8 — Voriconazole is usual care beside what is tested
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 YearsRecruitingPhase 1Actio Biosciences, Inc.NCT07156201Written as Voriconazole
- Venetoclax With Hypomethylating Agents in Newly Diagnosed AML Unfit for Intensive ChemotherapyCompletedPhase 4Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshNCT07773909Written as Voriconazole
- Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host DiseaseCompletedPhase 2National Cancer Institute (NCI)NCT04294641Written as Voriconazole
- Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedPhase 1/2Astellas Pharma Global Development, Inc.NCT02014558Written as Voriconazole
- Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary AspergillosisTerminatedPhase 2Scynexis, Inc.NCT03672292Written as Voriconazole
- Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric SubjectsWithdrawnPhase 3PfizerNCT01188759Written as Voriconazole
- Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive AspergillosisCompletedPhase 3PfizerNCT00531479Written as voriconazole
- Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive CandidiasisCompletedPhase 4PfizerNCT00496197Written as Vfend (voriconazole)
As the comparator · 8 — what is tested is compared with Voriconazole
- A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of PhototoxicityCompletedPhase 1National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NCT00353158Written as Voriconazole
- Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida InfectionsCompletedPhase 3Astellas Pharma IncNCT00413218Written as Voriconazole
- Isavuconazole (BAL8557) for Primary Treatment of Invasive AspergillosisCompletedPhase 3Astellas Pharma IncNCT00412893Written as Voriconazole
- Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell TransplantCompletedPhase 3Children's Oncology GroupNCT01503515Written as Voriconazole
- A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)CompletedPhase 3Merck Sharp & Dohme LLCNCT01782131Written as Voriconazole
- Au-Ag-Cu2O NG With PTT Anti Drug-resistant Microbial KeratitisStatus unknownEarly Phase 1Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT05268718Written as Voriconazole eye drops
- Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep MycosisCompletedPhase 3Asahi Kasei Pharma CorporationNCT03471988Written as Voriconazole
- Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)CompletedPhase 3Merck Sharp & Dohme LLCNCT02180165Written as Voriconazole
Codes
What other systems call Voriconazole · ClinicalTrials.gg INT008991
- MeSH (NLM) D065819VoriconazoleConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) JFU09I87TRVORICONAZOLEConfirmed FDA, NLM, Wikidata
- RxNorm 121243Confirmed FDA, Wikidata
- Wikidata Q412236voriconazoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1707VoriconazoleConfirmed FDA, Wikidata
- DrugBank DB00582One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D065819 | Voriconazole | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | JFU09I87TR | VORICONAZOLE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 121243 | — | Confirmed FDA, Wikidata |
| Wikidata | Q412236 | voriconazole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1707 | Voriconazole | Confirmed FDA, Wikidata |
| DrugBank | DB00582 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.